Company / Net Income
Opus Genetics, Inc. Net Income History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$57.5M
FY2025
5-year range
-$57.5M / $17.9M
FY2021-FY2025
Trend
-476.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income changed -476% YoY in FY2025, a notable deviation from the 6-year average annual change of -732%.
Based on SEC 10-K filings.
-$58M in FY2025.
Declined from $18M to -$58M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 476.1% year-over-year.
- Peak net income was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$57.5M | -476.1% |
| FY2024 | -$10.0M | -155.8% |
| FY2023 | $17.9M | +131.6% |
| FY2022 | -$56.7M | -130.3% |
| FY2021 | -$24.6M | -3838.5% |
| FY2013 | -$625.1K | +78.5% |
| FY2011 | -$2.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026